Craig-Hallum Assumes Avadel Pharmaceuticals (AVDL) at Buy
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Price: $21.64 --0%
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Craig-Hallum analyst Robin Garner assumes coverage on Avadel Pharmaceuticals (NASDAQ: AVDL) with a Buy rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Avadel Pharmaceuticals click here. For more ratings news on Avadel Pharmaceuticals click here.
Shares of Avadel Pharmaceuticals closed at $4.55 yesterday.
You May Also Be Interested In
- Morgan Stanley Starts Rio Tinto (RIO) at Underweight
- Morgan Stanley Starts Arcelor Mittal (MT) at Overweight
- Keefe, Bruyette & Woods Resumes Bank of Nova Scotia (BNS:CN) (BNS) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
